A mutated gene could be responsible for triggering prostate cancer, new research has found.
The relevant gene, p53, encodes a protein that normally operates as tumour suppressor by preventing the replication DNA damaged cells. The p53 has previously been associated with the disease’s progression, but this is the first instance of association in the early stages.
The researchers hope that the findings will develop onto a diagnostic test for prostate cancer, as well as promoting understanding of the disease.
Read more at University of California Davis